Literature DB >> 34996644

Effect of the framing of HPV vaccination on parents' willingness to accept an HPV vaccine.

Zhuoying Huang1, Mengdi Ji2, Jia Ren1, Xiaodong Sun1, Matthew L Boulton3, Brian J Zikmund-Fisher4, Abram L Wagner5.   

Abstract

In China, HPV vaccines are not mandatory and have low uptake. In light of the U.S.'s experience in rolling out the vaccine with an initial focus primarily on HPV as a sexually transmitted infection but transitioning later to cancer messaging, we used a multifactorial experiment to create several different messages about the HPV vaccine across age, communicability, and cancer domains. In this study, we assess the effect of the different messages on willingness to accept an HPV vaccine, and characterize how parental sociodemographics and the age/gender of a child also impact willingness to obtain an HPV vaccine. In total, 1,021 parents of children aged<18 years old in Shanghai, China were randomized to receive a message about cancer (HPV causes cervical cancers vs cancers in general), infectiousness (HPV is sexually transmitted, or is an infectious disease in general, or not mentioned), and recommended age of vaccination (before middle school, before college/work, or not mentioned). Parents were asked if they would vaccinate a hypothetical son or daughter of different ages 6, 12, or 18 years old). In a multivariable logistic regression model adjusting for parental sociodemographic characteristics, parents were more likely to want to vaccinate a daughter vs a son, and an older vs younger child. Messaging had some effect in certain circumstances: parents were more likely to accept a vaccine for a 6-year-old son if given information that it protected against cancers in general. Providing information about a sexually transmitted infection led to higher willingness to vaccinate a son 6 years old and a daughter 6 or 12 years old. This study showed messaging had some limited impact on willingness to vaccinate against HPV, but more research is needed on how to increase uptake of the HPV vaccine when it is not publicly funded.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adolescent; China; Female; Male; Papillomavirus vaccines

Mesh:

Substances:

Year:  2022        PMID: 34996644      PMCID: PMC8816874          DOI: 10.1016/j.vaccine.2021.12.051

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  23 in total

1.  Parents' hesitancy towards vaccination in Indonesia: A cross-sectional study in Indonesia.

Authors:  Amanda Yufika; Abram Luther Wagner; Yusuf Nawawi; Nur Wahyuniati; Samsul Anwar; Fitria Yusri; Novi Haryanti; Nanda Putri Wijayanti; Rizal Rizal; Devi Fitriani; Nurul Fadhliati Maulida; Muhammad Syahriza; Ikram Ikram; Try Purwo Fandoko; Muniati Syahadah; Febrivan Wahyu Asrizal; Alma Aletta; Sotianingsih Haryanto; Kurnia Fitri Jamil; Mudatsir Mudatsir; Harapan Harapan
Journal:  Vaccine       Date:  2020-02-01       Impact factor: 3.641

2.  "It All Depends": A Qualitative Study of Parents' Views of Human Papillomavirus Vaccine for their Adolescents at Ages 11-12 years.

Authors:  Caitlin E Hansen; Marisol Credle; Eugene D Shapiro; Linda M Niccolai
Journal:  J Cancer Educ       Date:  2016-03       Impact factor: 2.037

3.  Significant decrease in the incidence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program.

Authors:  Louise Baandrup; Maria Blomberg; Christian Dehlendorff; Carsten Sand; Klaus K Andersen; Susanne K Kjaer
Journal:  Sex Transm Dis       Date:  2013-02       Impact factor: 2.830

Review 4.  Population impact of HPV vaccines: summary of early evidence.

Authors:  Susan Hariri; Lauri E Markowitz; Eileen F Dunne; Elizabeth R Unger
Journal:  J Adolesc Health       Date:  2013-12       Impact factor: 5.012

Review 5.  Predictors of HPV vaccine acceptability: a theory-informed, systematic review.

Authors:  Noel T Brewer; Karah I Fazekas
Journal:  Prev Med       Date:  2007-06-02       Impact factor: 4.018

6.  Human papillomavirus vaccines: WHO position paper, May 2017-Recommendations.

Authors: 
Journal:  Vaccine       Date:  2017-06-05       Impact factor: 3.641

7.  Vaccine Hesitancy and Concerns About Vaccine Safety and Effectiveness in Shanghai, China.

Authors:  Abram L Wagner; Zhuoying Huang; Jia Ren; Megan Laffoon; Mengdi Ji; Leah C Pinckney; Xiaodong Sun; Lisa A Prosser; Matthew L Boulton; Brian J Zikmund-Fisher
Journal:  Am J Prev Med       Date:  2020-11-12       Impact factor: 5.043

8.  On the implications of desexualizing vaccines against sexually transmitted diseases: health policy challenges in a multicultural society.

Authors:  Baruch Velan; Yaacov Yadgar
Journal:  Isr J Health Policy Res       Date:  2017-07-01

9.  Chinese Vaccine Providers' Perspectives on the HPV Vaccine.

Authors:  Mengdi Ji; Zhuoying Huang; Jia Ren; Xiaodong Sun; Abram L Wagner
Journal:  Glob Pediatr Health       Date:  2020-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.